Shareholder action notice: the schall law firm encourages investors in nrx pharmaceuticals, inc. with losses of $100,000 to contact the firm

Los angeles, california--(newsfile corp. - january 28, 2022) - the schall law firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against nrx pharmaceuticals, inc. ("nrx" or "the company") (nasdaq: nrxp) for violations of §§10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission.investors who purchased the company's securities between june 1, 2021 and november 4, 2021, inclusive...
NRXP Ratings Summary
NRXP Quant Ranking